The Effect of Nebulized Albuterol on Donor Oxygenation

PHASE2CompletedINTERVENTIONAL
Enrollment

506

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

May 31, 2011

Study Completion Date

June 30, 2011

Conditions
Brain DeathOrgan DonorPulmonary Edema
Interventions
DRUG

Albuterol

5 mg nebulized q4h

DRUG

Saline

1.0 cc diluted with saline in identical fashion to study drug and administered by nebulizer every 4 hours

Trial Locations (1)

94612

California Transplant Donor Network, Oakland

All Listed Sponsors
collaborator

California Transplant Donor Network

NETWORK

collaborator

University of California, San Francisco

OTHER

lead

Vanderbilt University Medical Center

OTHER

NCT00310401 - The Effect of Nebulized Albuterol on Donor Oxygenation | Biotech Hunter | Biotech Hunter